pulseData uses patented AI to better diagnose, risk stratify and predict adverse events for patients with chronic kidney disease or disorders involving both the heart and the kidneys.
Our software drives preventive action, saves medical costs and helps eliminate suffering and we’re on a mission to help eliminate preventable sickness.
Our software drives preventive action, saves medical costs and helps eliminate suffering and we’re on a mission to help eliminate preventable sickness.
Location: United States, New York
Employees: 11-50
Total raised: $16.5M
Founded date: 2015
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.04.2021 | Series A | $16.5M | - |
Mentions in press and media 9
| Date | Title | Description |
| 28.07.2021 | Digital therapy: focus on results, not technology: investments, trends, new development challenges. Part 2 | Digital therapy: focus on results, not technology: investments, trends, new development challenges. Part 2 |
| 28.07.2021 | Цифровая терапия — фокус на результат, а не на технологию: инвестиции, тренды, новые вызовы развития. Часть 2 | Цифровая терапия — фокус на результат, а не на технологию: инвестиции, тренды, новые вызовы развития. Часть 2 |
| 26.05.2021 | Vytalize Health Innovation Lab Selects pulseData's AI-Powered Platform for Chronic Kidney Disease | NEW YORK, May 26, 2021 /PRNewswire/ -- pulseData has developed an industry-leading algorithm to predict kidney disease progression in the United States, a devastating and costly disease. The company can predict with amazing accuracy if a pe... |
| 22.04.2021 | Healthcare startup pulseData raises $16.5M funding to enable early kidney failure intervention using machine learning and predictive algorithms | According to the Centers for Disease Control and Prevention (CDC), kidney diseases are the ninth leading cause of death in the United States. About 37 million US adults are estimated to have CKD and most are undiagnosed. 40% of adults with ... |
| 21.04.2021 | pulseData Raises $16.5M in Series A Funding | pulseData, a New York City-based healthcare data science company focused on predictive algorithms for Chronic Kidney Disease and other chronic diseases, raised $16.5m in Series A funding. The round was led by Bain Capital Private Equity and... |
| 21.04.2021 | pulseData Raises $16.5 Million in Series A Funding Led by Bain Capital Private Equity and Two Bear Capital | NEW YORK, April 21, 2021 /PRNewswire/ -- pulseData, a New York City-based healthcare data science company, focused on predictive algorithms for Chronic Kidney Disease and other chronic diseases, today announced $16.5 million in Series A fun... |
| 19.04.2021 | Healthcare Startup pulseData Raises $16.5M To Help Lower Costs To Treat Kidney Disease | The U.S. healthcare system is more reactive than proactive in promoting good health to its patients. Essential care is only delivered for chronic diseases after a critical illness strikes an individual and not before. The shift from a fee-b... |
| 12.07.2017 | Grand Central Tech unveils its fourth class of startups | Grand Central Tech is kicking off the fourth year of its startup accelerator. As its name suggests, the organization is located near New York City’s Grand Central station. It’s not just an accelerator anymore — it also runs a coworking spac... |
| 02.05.2017 | The Network for In-Home Care: Why We Invested in PreparedHealth | Just as our President is discovering the intricacies of the US healthcare system, the average citizen, particularly our seniors, is watching our system’s complexity begin to weigh on the creaking (and shifting) foundation on which it stands... |